Weixian Lu

1000 citations
15 papers · 797 indexed · h-index 12
Topics
Wnt/β-catenin signaling in development and cancer (6 papers)Protein Tyrosine Phosphatases (4 papers)Glycosylation and Glycoproteins Research (3 papers)

In The Last Decade

Weixian Lu

15 papers receiving 789 citations

Peers

Weixian Lu
Comparison fields: 5 of 86
  • Molecular Biology 565
  • Cell Biology 200
  • Cellular and Molecular Neuroscience 185
  • Immunology 119
  • Genetics 82
Replace Ruth Herbst with:
Ruth Herbst Austria
Yarden Opatowsky Israel
Maud Martin Belgium
Eléna Kardash Germany
Marilyn Parra United States
Kiyotoshi Satoh Japan
Joseph Tcherkezian Canada
Charles L. Farnsworth United States
Xiaoying Jian United States
Qingwen Wan United States
Weixian Lu relative to Ruth Herbst Austria Ruth Herbst's profile →
Citations per field
00.5×1.6×
Ruth Herbst · 1×
Citations per year

Countries citing papers authored by Weixian Lu

Since Specialization
Citations

This map shows the geographic impact of Weixian Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weixian Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weixian Lu more than expected).

Fields of papers citing papers by Weixian Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weixian Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weixian Lu. The network helps show where Weixian Lu may publish in the future.

Co-authorship network of co-authors of Weixian Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Weixian Lu. A scholar is included among the top collaborators of Weixian Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weixian Lu. Weixian Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 6
2 8
3 15
4 32
5 23
6 13
7 22
8 67
9 8
10 13
11 49
12 127
13 255
14 90
15 69

About Weixian Lu

Weixian Lu is a scholar working on Molecular Biology, Immunology and Allergy and Endocrine and Autonomic Systems, having authored 15 papers that have together received 797 indexed citations. Recurring topics across this work include Wnt/β-catenin signaling in development and cancer (6 papers), Protein Tyrosine Phosphatases (4 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Cell Biology (200 citations), Cellular and Molecular Neuroscience (185 citations) and Developmental Neuroscience (35 citations). Weixian Lu has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include E. Yvonne Jones, A.R. Aricescu, Christian Siebold, C.H. Coles, John G. Flanagan, Alan P. Tenney, Yingjie Shen, Yuguang Zhao, Tomas Malinauskas and Geoffrey C. Sutton. Their work appears in journals such as Science, Nature Communications and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026